Valneva provides regulatory update on its inactivated covid-19 vaccine candidate

Saint herblain (france), april 25 , 2022 – valneva se (nasdaq: valn; euronext paris: vla), a specialty vaccine company, today provided an update on the rolling review process of its inactivated, covid-19 vaccine candidate, vla2001, with the committee for medicinal products for human use (“chmp”) of the european medicines agency (“ema”).
VALN Ratings Summary
VALN Quant Ranking